Semax
ACTH(4-10)-derived heptapeptide. Approved in Russia for stroke/cognitive research.
Neuroregulation Research Peptides
ORG-2766 is a synthetic analog of ACTH(4-9), developed by Organon and studied since the 1980s for neurotrophic and cognition-related effects while lacking ACTH's steroidogenic activity. It is supplied as a legacy research-grade reference compound for memory, peripheral-nerve-injury, and neuroinflammation studies.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
ACTH(4-10)-derived heptapeptide. Approved in Russia for stroke/cognitive research.
N-acetylated, stability-enhanced Semax derivative.
Tuftsin-derived heptapeptide. Approved in Russia for anxiety.